ALYSE STOLTING: Open Payments
NPI 1407275514 · TOLEDO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$128 in 6 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $49 · 2025 $128
Food & beverage: $128
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 2 | $35 |
| Neurocrine BioSciences, Inc. | 1 | $34 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| ABBVIE INC. | 1 | $18 |
Products named: ARISTADA, INGREZZA, ABILIFY ASIMTUFII, CAPLYTA, VRAYLAR.
Industry payments across OH — which companies pay providers there.
